OPKO HEALTH, INC.
OPKUS売上高
$607M
百万USD
営業利益
$-117M
百万USD
純利益
$-226M
百万USD
ROE
-17.8%
最新FY
EPS
$-0.30
USD / 株
配当
-
USD / 株
業績推移
収益性
キャッシュフロー
財務状況
四半期業績
| 年度 | 期 | 売上高 | 純利益 | EPS |
|---|---|---|---|---|
| FY2021 | Q1 | $545M | $31M | - |
| FY2021 | Q2 | $442M | $-16M | $-0.03 |
| FY2021 | Q3 | $386M | $29M | $0.04 |
| FY2021 | FY | $1.8B | $-30M | $-0.05 |
| FY2022 | Q1 | $329M | $-55M | $-0.08 |
| FY2022 | Q2 | $310M | $-102M | $-0.14 |
| FY2022 | Q3 | $180M | $-86M | $-0.11 |
| FY2022 | FY | $1.0B | $-328M | $-0.46 |
| FY2023 | Q1 | $238M | $-18M | $-0.02 |
| FY2023 | Q2 | $265M | $-20M | - |
| FY2023 | Q3 | $179M | $-84M | - |
| FY2023 | FY | $863M | $-189M | - |
| FY2024 | Q1 | $174M | $-82M | - |
| FY2024 | Q2 | $182M | $-10M | - |
| FY2024 | Q3 | $174M | $25M | $0.03 |
| FY2024 | FY | $713M | $-53M | - |
| FY2025 | Q1 | $150M | $-68M | - |
| FY2025 | Q2 | $157M | $-148M | $-0.19 |
| FY2025 | Q3 | $152M | $22M | $0.03 |
| FY2025 | FY | $607M | $-226M | $-0.30 |
| FY2026 | Q1 | $124M | $-55M | $-0.07 |
財務データ
| 指標 | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| 売上高 | - | - | $990M | $902M | $1.4B | $1.8B | $1.0B | $863M | $713M | $607M |
| 営業利益 | $-73M | $-280M | $-171M | $-274M | $58M | $19M | $-226M | $-157M | $-152M | $-117M |
| 純利益 | $-25M | $-309M | $-153M | $-315M | $31M | $-30M | $-328M | $-189M | $-53M | $-226M |
| 総資産 | $2.8B | $2.6B | $2.5B | $2.3B | $2.5B | $2.4B | $2.2B | $2.0B | $2.2B | $1.9B |
| 純資産 | $2.1B | $1.9B | $1.8B | - | - | - | $1.6B | - | - | - |
| 自己資本 | - | - | - | $1.6B | $1.7B | $1.7B | - | $1.4B | $1.4B | $1.3B |
| 営業CF | $32M | $-92M | $-109M | $-173M | $39M | $38M | $-95M | $-28M | $-183M | $-179M |
| EPS | - | - | $-0.27 | - | - | $-0.05 | $-0.46 | - | - | $-0.30 |
| BPS | - | - | - | $2.41 | $2.49 | $2.47 | - | $1.99 | $2.03 | $1.67 |
| ROE | - | - | - | -19.5% | 1.8% | -1.8% | - | -13.6% | -3.9% | -17.8% |